{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:51:46Z","timestamp":1781070706328,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jiac.2023.11.015","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T05:08:33Z","timestamp":1700284113000},"page":"423-428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk factors for cefmetazole-non-susceptible bacteremia in acute cholangitis"],"prefix":"10.1016","volume":"30","author":[{"given":"Katsuhiro","family":"Onishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0299-040X","authenticated-orcid":false,"given":"Hiroshi","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3831-7241","authenticated-orcid":false,"given":"Takahiro","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Tsuchimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Komiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2023.11.015_bib1","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJM199206113262401","article-title":"Endoscopic biliary drainage for severe acute cholangitis","volume":"326","author":"Lai","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2023.11.015_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jhbp.509","article-title":"Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis","volume":"25","author":"Miura","year":"2018","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jiac.2023.11.015_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archsurg.1969.01340110121014","article-title":"The significance of biliary pressure in cholangitis","volume":"98","author":"Huang","year":"1969","journal-title":"Arch Surg"},{"key":"10.1016\/j.jiac.2023.11.015_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00534-006-1157-6","article-title":"Antimicrobial therapy for acute cholangitis: Tokyo Guidelines","volume":"14","author":"Tanaka","year":"2007","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.jiac.2023.11.015_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12876-020-01201-6","article-title":"Use of microbiological and patient data for choice of empirical antibiotic therapy in acute cholangitis","volume":"20","author":"Kruis","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jiac.2023.11.015_bib6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00534-006-1163-8","article-title":"Results of the Tokyo consensus meeting Tokyo guidelines","volume":"14","author":"Mayumi","year":"2007","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.jiac.2023.11.015_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jhbp.518","article-title":"Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis","volume":"25","author":"Gomi","year":"2018","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jiac.2023.11.015_bib8","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1128\/AAC.00701-15","article-title":"Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-beta-lactamase-producing Escherichia coli bacteremia","volume":"59","author":"Matsumura","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.11.015_bib9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s10620-012-2478-8","article-title":"Risk factors of organ failure in patients with bacteremic cholangitis","volume":"58","author":"Lee","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jiac.2023.11.015_bib10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10620-012-2398-7","article-title":"Clinical impact of extended-spectrum beta-lactamase-producing Enterobacteriaceae in patients with biliary tract infection","volume":"58","author":"Kim","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jiac.2023.11.015_bib11","series-title":"Performance Standards for antimicrobial susceptibility testing\u2014twenty-sixth edition: M100","year":"2016"},{"key":"10.1016\/j.jiac.2023.11.015_bib12","first-page":"403","article-title":"Cefoxotin, cefotetan, and other cephamycins","volume":"vol. 1","author":"Daveson","year":"2018"},{"key":"10.1016\/j.jiac.2023.11.015_bib13","series-title":"xPharm: the comprehensive pharmacology reference","year":"2007"},{"key":"10.1016\/j.jiac.2023.11.015_bib14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2023.11.015_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002390","article-title":"Microbiological assessment of bile and corresponding antibiotic treatment: a strobe-compliant observational study of 1401 endoscopic retrograde cholangiographies","volume":"95","author":"Rupp","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jiac.2023.11.015_bib16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1055\/a-1790-1314","article-title":"Microbiology of bile aspirates obtained at ERCP in patients with suspected acute cholangitis","volume":"54","author":"Gromski","year":"2022","journal-title":"Endoscopy"},{"key":"10.1016\/j.jiac.2023.11.015_bib17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.clinre.2014.02.005","article-title":"How to interpret the bile culture results of patients with biliary tract infections","volume":"38","author":"Park","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jiac.2023.11.015_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijid.2020.04.074","article-title":"Three-day antibiotic treatment for acute cholangitis due to choledocholithiasis with successful biliary duct drainage: a single-center retrospective cohort study","volume":"96","author":"Satake","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2023.11.015_bib19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.5009\/gnl20214","article-title":"Risk factors for acute cholangitis caused by Enterococcus faecalis and Enterococcus faecium","volume":"15","author":"Karasawa","year":"2021","journal-title":"Gut Liver"},{"key":"10.1016\/j.jiac.2023.11.015_bib20","article-title":"Effect of antibiotic resistance of pathogens on initial antibiotic therapy for patients with cholangitis","volume":"13","author":"Masuda","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jiac.2023.11.015_bib21","doi-asserted-by":"crossref","first-page":"985","DOI":"10.5009\/gnl210474","article-title":"Changing patterns of causative pathogens over time and efficacy of empirical antibiotic therapies in acute cholangitis with bacteremia","volume":"16","author":"Jeong","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.jiac.2023.11.015_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00051-22","article-title":"Risk factors and predictive score for bacteremic biliary tract infections due to Enterococcus faecalis and Enterococcus faecium: a multicenter cohort study from the PROBAC Project","volume":"10","author":"Mussa","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jiac.2023.11.015_bib23","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/medicina59040721","article-title":"Identification of microbial species and analysis of antimicrobial resistance patterns in acute cholangitis patients with malignant and benign biliary obstructions: a comparative study","volume":"59","author":"Miu\u0163escu","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jiac.2023.11.015_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jiac.2021.11.025","article-title":"Microbiological analysis of patients with first and recurrent episodes of acute cholangitis in a middle-sized hospital: a single-center retrospective study in rural North Kyoto, Japan","volume":"28","author":"Hara","year":"2022","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2023.11.015_bib25","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.2147\/IDR.S418752","article-title":"Analysis of pathogenic bacteria distribution and related factors in recurrent acute cholangitis","volume":"16","author":"Li","year":"2023","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jiac.2023.11.015_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jiac.2021.10.004","article-title":"Blood cultures should be collected for acute cholangitis regardless of severity","volume":"28","author":"Otani","year":"2022","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2023.11.015_bib27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/jhbp.452","article-title":"Updated comprehensive epidemiology, microbiology, and outcomes among patients with acute cholangitis","volume":"24","author":"Gomi","year":"2017","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jiac.2023.11.015_bib28","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/00365521.2021.1902558","article-title":"Analysis of patterns of bacteremia and 30-day mortality in patients with acute cholangitis over a 25-year period","volume":"56","author":"Tan","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jiac.2023.11.015_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/00365548.2012.730151","article-title":"Clinical impact of inappropriate initial antimicrobial therapy on outcome in bacteremic biliary tract infections","volume":"45","author":"Kang","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jiac.2023.11.015_bib30","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmi.2017.02.027","article-title":"Impact of inadequate initial antimicrobial therapy on mortality in patients with bacteraemic cholangitis: a retrospective cohort study","volume":"23","author":"Tagashira","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2023.11.015_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13054-021-03480-1","article-title":"Acute cholangitis in intensive care units: clinical, biological, microbiological spectrum and risk factors for mortality: a multicenter study","volume":"25","author":"Lavillegrand","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2023.11.015_bib32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/ajg.2011.387","article-title":"The clinical epidemiology and outcomes of bacteremic biliary tract infections caused by antimicrobial-resistant pathogens","volume":"107","author":"Sung","year":"2012","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23002878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23002878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T11:25:08Z","timestamp":1714994708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X23002878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1341321X23002878"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2023.11.015","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for cefmetazole-non-susceptible bacteremia in acute cholangitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2023.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}